Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study.
about
A review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proofCarboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.Targeting tumor metastases: Drug delivery mechanisms and technologies.Evaluation of a novel tissue stabilization gel to facilitate clinical sampling for translational research in surgical trials.Transarterial chemoembolization (TACE) for colorectal liver metastases--current status and critical review.The state of regional therapy in the management of metastatic colorectal cancer to the liver.Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.An Overview of the Current Management of Bilobar Colorectal Liver Metastases.The power of genes: a case of unusually severe systemic toxicity after localized hepatic chemoembolization with irinotecan-eluted microspheres for metastatic colon cancer.The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer.
P2860
Q27022812-8FFF7CD0-5944-4336-BFC0-466BA789D784Q36009614-6F8518F0-5B1B-4FD5-ADB8-8520CB48DB12Q36557855-153AE525-7D4D-40AE-9232-F914F66E9834Q38388188-ED4C8D7A-5CA8-4A3A-AE64-2E3A040FD2FDQ38531685-84175ADC-FE1C-4538-AB39-F95D8774AB31Q38664762-77869BCD-4A63-4212-A028-4010159CFE8BQ41015601-5742B67C-3682-44D1-A959-0DD6C9DA4697Q50080198-B46DB9FB-B4A5-4EF6-BDF6-51327DD92801Q51040976-042C0EEB-7195-4DDF-810A-268FB5084E62Q55252442-80373B4A-BDFB-40A5-AC01-3270A93B65BA
P2860
Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Hepatic activation of irinotec ...... indings from a phase II study.
@en
Hepatic activation of irinotec ...... indings from a phase II study.
@nl
type
label
Hepatic activation of irinotec ...... indings from a phase II study.
@en
Hepatic activation of irinotec ...... indings from a phase II study.
@nl
prefLabel
Hepatic activation of irinotec ...... indings from a phase II study.
@en
Hepatic activation of irinotec ...... indings from a phase II study.
@nl
P2093
P2860
P1476
Hepatic activation of irinotec ...... indings from a phase II study.
@en
P2093
A Santoyo-Castelazo
G J Poston
M Terlizzo
N R Kitteringham
P2860
P2888
P304
P356
10.1007/S00280-013-2199-5
P577
2013-06-12T00:00:00Z